Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Alpha-1 Antitrypsin Augmentation Therapy Improves Survival in Severely Deficient Patients with Predicted FEV1 Between 10% and 60%: A Retrospective Analysis of the NHLBI Alpha-1 Antitrypsin Deficiency Registry

International Journal of COPD(2020)10.2147/copd.s263725Source: DataRank Database

Alpha-1 Antitrypsin Augmentation Therapy Improves Survival in Severely Deficient Patients with Predicted FEV1 Between 10% and 60%: A Retrospective Analysis of the NHLBI Alpha-1 Antitrypsin Deficiency Registry is a research paper published in International Journal of COPD (2020). On theSindex it has a DataRank of 0. It has been cited 24 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access24 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 1.12)OA: goldTopics (40)Linked Datasets (8)DataCite Reuse (8)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Richard Monk,Viswanathan Ramakrishnan ORCID,Tatsiana Beiko,Charlie Strange ORCID,Franck Rahaghi ORCID

Live enrichment

PubMed:33299307 PMC:PMC7721109 OpenAlex:https://openalex.org/W3110023642

National Institutes of Health

Grant: N01HR086036-014

CONGENITAL DEFICIENCY OF ALPHA1-ANTITRYPSIN REGISTRY

FWCI

1.12

Citation Percentile

0.8%

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: cc-by-nc

journalhttps://www.dovepress.com/getfile.php?fileID=64446

publisherhttps://www.dovepress.com/getfile.php?fileID=64446

journalhttps://doi.org/10.2147/copd.s263725

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33299307

repositoryhttps://www.dovepress.com/alpha-1-antitrypsin-augmentation-therapy-improves-survival-in-severely-peer-reviewed-article-COPD

Fields of Study

Protease and Inhibitor MechanismsThyroid Disorders and TreatmentsChronic Obstructive Pulmonary Disease (COPD) Research03 medical and health sciences0302 clinical medicine

MeSH Terms

alpha 1-AntitrypsinForced Expiratory VolumeHumansRegistriesRetrospective StudiesUnited Statesalpha 1-Antitrypsin DeficiencyPulmonary Disease, Chronic ObstructiveNational Heart, Lung, and Blood Institute (U.S.)

Keywords

MedicineAlpha 1-antitrypsin deficiencyAlpha (finance)Internal medicineRetrospective cohort studyGastroenterologySurgeryPatient satisfactionMortalitySurvivalCOPDFev1Alpha-1 Antitrypsin DeficiencyAugmentation TherapyRC705-779International Journal of Chronic Obstructive Pulmonary DiseaseUnited StatesDiseases of the respiratory systemPulmonary Disease, Chronic ObstructiveForced Expiratory Volumealpha 1-AntitrypsinHumansRegistriesNational Heart, Lung, and Blood Institute (U.S.)Original ResearchRetrospective Studies

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 1 of The impact of diagnostic delay on survival in alpha-1-antitrypsin deficiency: results from the Austrian Alpha-1 Lung Registry

10.6084/m9.figshare.22610806.v1figshare

Additional file 1 of The impact of diagnostic delay on survival in alpha-1-antitrypsin deficiency: results from the Austrian Alpha-1 Lung Registry

10.6084/m9.figshare.22610806figshare

Additional file 2 of The impact of diagnostic delay on survival in alpha-1-antitrypsin deficiency: results from the Austrian Alpha-1 Lung Registry

10.6084/m9.figshare.22610809.v1figshare

Additional file 2 of The impact of diagnostic delay on survival in alpha-1-antitrypsin deficiency: results from the Austrian Alpha-1 Lung Registry

10.6084/m9.figshare.22610809figshare

Additional file 3 of The impact of diagnostic delay on survival in alpha-1-antitrypsin deficiency: results from the Austrian Alpha-1 Lung Registry

10.6084/m9.figshare.22610812.v1figshare